Archive - March 2021
GSK to assist in manufacturing up to 60 million doses of Novavax’s COVID-19 vaccine in the UK
Lilly, Vir and GSK’s antibodies reduce viral load by 70% in low-risk COVID-19 patients
EU authorises Roche’s spinal muscular atrophy treatment Evrysdi
Novartis gains EU approval for relapsing MS drug Kesimpta
EU approval for new AI technology that can predict heart attacks
FDA green light for BMS, bluebird bio’s CAR-T therapy Abecma in multiple myeloma
Inctye’s Pemazyre authorised in the EU for bile duct cancer
GSK agrees to support manufacture of Novavax’ COVID-19 vaccine